Review of Levetiracetam as a First Line Treatment in Status Epilepticus in the Adult Patients- What do we know so far?

Frontiers in Neurology

Hae Won eShin¹  Robin eDavis¹ 

[1] University of North Carolina Health Care;

关键词: Status Epilepticus;    seizure;    levetiracetam;    antiepileptic drug;    First line therapy for the status epilepticus;   

DOI  :  10.3389/fneur.2013.00111

来源: DOAJ

【 摘 要 】

With the advent of new antiepileptic drugs comes the potential for significant advances in the emergent management of status epilepticus. Traditional antiepileptic drugs possess side effect profiles that may limit their clinical utility or lead to increased patient morbidity or mortality. The relatively recent development of levetiracetam shows promise for effective control of acute status epilepticus in adults, but current objective data of its use as a first-line agent for control of status is quite limited. This paper serves to examine existing literature while considering levetiracetam as a first-line therapy in status in the adult patient population. Indeed, existing studies are narrow in their scope, however the present data do lay a substantial foundation for further investigation of levetiracetam as a primary therapy in acute status epilepticus.

【 授权许可】

Unknown